No Data
Express News | Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (Viloxazine) in Canada
Knight Therapeutics Announces Filing of New Drug Submission for Qelbree (Viloxazine) in Canada
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Supernus Pharmaceuticals (SUPN) and Skye Bioscience (SKYE)
Piper Sandler Sticks to Their Hold Rating for Supernus Pharmaceuticals (SUPN)
Screening For Black Friday Bargains In The Stock Market